Sciton, Inc. articles

An estimated 15.5 million adults have used a GLP-1 weight-loss drug. A national Gallup poll finds about 75% of Americans are familiar with GLP-1 therapies, and more than half view these treatments as a strong option for obesity or weight-related health challenges. In practice, patients report rapid weight loss followed by skin changes often described as Ozempic face, including hollowing in the cheeks, under-eye depressions, laxity along the jawline and neck, and a decline in overall skin qual